Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea ... risks for drug-resistant bacteria ...
The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand name for its 40mg minocycline hydrochloride extended-release capsules, to be used in the treatment ...
The drug was cleared to treat inflammatory ... a successful launch and to establish Emrosi as a new standard of care in the treatment of rosacea.” Patients should be able to get their hands ...
Remember, it's important to test any new products on a patch ... any irritation or worsening of your rosacea symptoms, stop using immediately. These medications may require a prescription ...